{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:26:11Z","timestamp":1770348371895,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:00:00Z","timestamp":1592524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:00:00Z","timestamp":1592524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX01031201"],"award-info":[{"award-number":["2018ZX01031201"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10067-020-05215-z","type":"journal-article","created":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T22:02:23Z","timestamp":1592604143000},"page":"701-710","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The clinical efficacy of urate-lowering therapy in acute gout: a meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"40","author":[{"given":"Xuexue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miaoran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongsheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8183-9945","authenticated-orcid":false,"given":"Qiuyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,19]]},"reference":[{"issue":"6","key":"5215_CR1","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/art.40807","volume":"71","author":"M Chen-Xu","year":"2019","unstructured":"Chen-Xu M, Yokose C, Rai SK, Pillinger MH, Choi HK (2019) Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and nutrition examination survey, 2007-2016. Arthritis Rheumatol 71(6):991\u2013999. https:\/\/doi.org\/10.1002\/art.40807","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"5215_CR2","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","volume":"11","author":"CF Kuo","year":"2015","unstructured":"Kuo CF, Grainge MJ, Zhang W, Doherty M (2015) Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 11(11):649\u2013662. https:\/\/doi.org\/10.1038\/nrrheum.2015.91","journal-title":"Nat Rev Rheumatol"},{"issue":"14","key":"5215_CR3","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3969\/j.issn.1007-9572.2018.00.132","volume":"21","author":"YF Xiong","year":"2018","unstructured":"Xiong YF, Zhao DB (2018) Interpretation of management of acute and recurrent gout:a clinical practice guideline from the American College of Physicians. Chin Gen Pract 21(14):1645\u20131647. https:\/\/doi.org\/10.3969\/j.issn.1007-9572.2018.00.132","journal-title":"Chin Gen Pract"},{"issue":"1","key":"5215_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E, Barskova V, Becce F, Casta\u00f1eda-Sanabria J, Coyfish M, Guillo S, Jansen TL, Janssens H, Liot\u00e9 F, Mallen C, Nuki G, Perez-Ruiz F, Pimentao J, Punzi L, Pywell T, So A, Tausche AK, Uhlig T, Zavada J, Zhang W, Tubach F, Bardin T (2017) 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 76(1):29\u201342. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209707","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"5215_CR5","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s00296-016-3579-z","volume":"36","author":"F Eminaga","year":"2016","unstructured":"Eminaga F, Le-Carratt J, Jones A, Abhishek A (2016) Does the initiation of urate-lowering treatment during an acute gout attack prolong the current episode and precipitate recurrent attacks: a systematic literature review. Rheumatol Int 36(12):1747\u20131752. https:\/\/doi.org\/10.1007\/s00296-016-3579-z","journal-title":"Rheumatol Int"},{"issue":"7","key":"5215_CR6","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/rheumatology\/kex150","volume":"56","author":"H Michelle","year":"2017","unstructured":"Michelle H, Alison C, Stewart C, Graham D, Michael D, Harry F et al (2017) The British Society for Rheumatology Guideline for the Management of Gout. Rheumatology 56(7):1056\u20131059. https:\/\/doi.org\/10.1093\/rheumatology\/kex150","journal-title":"Rheumatology"},{"issue":"6","key":"5215_CR7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jbspin.2015.02.021","volume":"82","author":"X Feng","year":"2015","unstructured":"Feng X, Li Y, Gao W (2015) Significance of the initiation time of urate-lowering therapy in gout patients: a retrospective research. Joint Bone Spine 82(6):428\u2013431. https:\/\/doi.org\/10.1016\/j.jbspin.2015.02.021","journal-title":"Joint Bone Spine"},{"issue":"8","key":"5215_CR8","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1007\/s10067-019-04566-6","volume":"38","author":"C Janssen","year":"2019","unstructured":"Janssen C, Oude Voshaar M, Ten K, Vonkeman H, Van de L (2019) Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare. Clin Rheumatol 38(8):2233\u20132239. https:\/\/doi.org\/10.1007\/s10067-019-04566-6","journal-title":"Clin Rheumatol"},{"issue":"3","key":"5215_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/RHU.0000000000000235","volume":"21","author":"EM Hill","year":"2015","unstructured":"Hill EM, Sky K, Sit M, Collamer A, Higgs J (2015) Does starting allopurinol prolong acute treated gout? A randomized clinical trial. J Clin Rheumatol 21(3):120\u2013125. https:\/\/doi.org\/10.1097\/RHU.0000000000000235","journal-title":"J Clin Rheumatol"},{"issue":"11","key":"5215_CR10","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.amjmed.2012.05.025","volume":"125","author":"TH Taylor","year":"2012","unstructured":"Taylor TH, Mecchella JN, Larson RJ, Kerin KD, MacKenzie TA (2012) Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized clinical trial. Am J Med 125(11):1126\u20131134. https:\/\/doi.org\/10.1016\/j.amjmed.2012.05.025","journal-title":"Am J Med"},{"issue":"4","key":"5215_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3969\/j.issn.2095-4174.2019.04.005","volume":"8","author":"ZM Zhang","year":"2019","unstructured":"Zhang ZM, Huang QQ, Qi ZY, Zhao ZW, Wu KY, Cheng YY et al (2019) Effect of initial hypouric acid therapy for acute gout on clinical efficacy and medication compliance. Rheumatism Arthritis 8(4):24\u201327. https:\/\/doi.org\/10.3969\/j.issn.2095-4174.2019.04.005","journal-title":"Rheumatism Arthritis"},{"issue":"3","key":"5215_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.13638\/j.issn.1671-4040.2015.03.033","volume":"15","author":"XF Zhang","year":"2015","unstructured":"Zhang XF, Zhong Q (2015) Effect of urate-lowering therapy on recurrence and serum uric acid in acute primary gout. Pract Clin J Integr Tradit Chin West Med 15(3):54\u201355. https:\/\/doi.org\/10.13638\/j.issn.1671-4040.2015.03.033","journal-title":"Pract Clin J Integr Tradit Chin West Med"},{"issue":"6","key":"5215_CR13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3760\/cma.j.issn.1000-6699.2019.06.007","volume":"35","author":"XF Wang","year":"2019","unstructured":"Wang XF, Zhang JZ, Wang T, Li WJ, Liu AH, Sun RX (2019) Effects of urate-lowering therapy on inflammatory responses, gout flares occurrances, and the achieved target rate of serum uric acid in acute gout. Chin J Endocrinol Metab 35(6):486\u2013490. https:\/\/doi.org\/10.3760\/cma.j.issn.1000-6699.2019.06.007","journal-title":"Chin J Endocrinol Metab"},{"issue":"5","key":"5215_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.13730\/j.issn.1009-2595.2019.05.004","volume":"33","author":"SK Ye","year":"2019","unstructured":"Ye SK, Li XY, Ren X, Chen HY, Niu J (2019) Application of febuxostat in patients with acute gouty arthritis. Mil Med J South China 33(5):307\u2013311. https:\/\/doi.org\/10.13730\/j.issn.1009-2595.2019.05.004","journal-title":"Mil Med J South China"},{"key":"5215_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang WQ, Liu JM, Tong TJ (2014) Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol 14:135. https:\/\/doi.org\/10.1186\/1471-2288-14-135","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"5215_CR16","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"DH Luo","year":"2018","unstructured":"Luo DH, Wan X, Liu JM, Tong TJ (2018) Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res 27(6):1785\u20131850. https:\/\/doi.org\/10.1177\/0962280216669183","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"5215_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.7326\/M16-0569","volume":"166","author":"A Qaseem","year":"2017","unstructured":"Qaseem A, McLean RM, Starkey M, Forciea MA (2017) Diagnosis of acute gout: a clinical practice guideline from the American College of Physicians. Ann Intern Med 166(1):52\u201357. https:\/\/doi.org\/10.7326\/M16-0569","journal-title":"Ann Intern Med"},{"issue":"1","key":"5215_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11926-001-0049-7","volume":"3","author":"RC Landis","year":"2001","unstructured":"Landis RC, Haskard DO (2001) Pathogenesis of crystal-induced inflammation. Curr Rheumatol Rep 3(1):36\u201341. https:\/\/doi.org\/10.1007\/s11926-001-0049-7","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"5215_CR19","doi-asserted-by":"crossref","first-page":"954","DOI":"10.4049\/jimmunol.163.2.954","volume":"163","author":"R Shenkar","year":"1999","unstructured":"Shenkar R, Abraham E (1999) Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia: roles of reactive oxygen intermediates, NF-kappa B, and cyclic AMP response element binding protein. J Immunol 163(2):954\u2013962","journal-title":"J Immunol"},{"issue":"11","key":"5215_CR20","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1093\/rheumatology\/kez198","volume":"58","author":"L Vranken","year":"2019","unstructured":"Vranken L, Boonen A, Spaetgens B (2019) Outcome measurement in acute gout: about constructs, perspectives, scales and timing. Rheumatology (Oxford) 58(11):1891\u20131893. https:\/\/doi.org\/10.1093\/rheumatology\/kez198","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"5215_CR21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/art.20405","volume":"51","author":"S Akira","year":"2004","unstructured":"Akira S, Hisashi Y, Naoyuki K (2004) A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum 51(3):321\u2013325. https:\/\/doi.org\/10.1002\/art.20405","journal-title":"Arthritis Rheum"},{"issue":"3","key":"5215_CR22","first-page":"577","volume":"28","author":"J Li-Yu","year":"2001","unstructured":"Li-Yu J, Clayburne G, Sieck M, Beutler A, Rull M, Eisner E et al (2001) Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout? J Rheumatol 28(3):577\u2013580","journal-title":"J Rheumatol"},{"key":"5215_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1471-2474-12-103","volume":"12","author":"P Primatesta","year":"2011","unstructured":"Primatesta P, Plana E, Rothenbacher D (2011) Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population. BMC Musculoskelet Disord 12:103. https:\/\/doi.org\/10.1186\/1471-2474-12-103","journal-title":"BMC Musculoskelet Disord"},{"key":"5215_CR24","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2147\/PPA.S97927","volume":"11","author":"T Aung","year":"2017","unstructured":"Aung T, Myung G, FitzGerald JD (2017) Treatment approaches and adherence to urate-lowering therapy for patients with gout. Patient Prefer Adher 11:795\u2013800. https:\/\/doi.org\/10.2147\/PPA.S97927","journal-title":"Patient Prefer Adher"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05215-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05215-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05215-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T17:15:39Z","timestamp":1696266939000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05215-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,19]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["5215"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05215-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,19]]},"assertion":[{"value":"19 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}